ArticleJournal of cardiothoracic surgery2026
Minimally invasive pulmonary valve replacement via left anterior mini-thoracotomy after Tetralogy of Fallot repair: a five-patient case series.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary regurgitation is a common long-term consequence after Tetralogy of Fallot (TOF) repair and often leads to right ventricular dilatation requiring pulmonary valve replacement (PVR). Redo sternotomy carries risks including cardiac injury and bleeding. Minimally invasive alternatives aim to reduce surgical trauma while maintaining procedural safety. CASE PRESENTATION: We report five consecutive patients (aged 9-44 years) with severe pulmonary regurgitation and right ventricular dilatation who underwent minimally invasive PVR via a left anterior mini-thoracotomy (LAMT). All procedures were performed on a beating heart using femorofemoral cardiopulmonary bypass and stented bioprosthetic valves. Mean cardiopulmonary bypass time was 37.8 min. No conversions to sternotomy, major complications, or mortality occurred. Patients were extubated after a mean of 9.6 h, and mean hospital stay was 6.8 days. At two-month follow-up, all patients demonstrated excellent prosthetic valve function and significant reduction in right ventricular size.
conclusionsLAMT-PVR is a feasible and safe alternative to redo sternotomy for selected post-TOF patients. This approach provides direct access to the pulmonary artery with reduced surgical trauma and favorable early outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.